ClinicalTrials.Veeva

Menu

Protocol for a Feasibility Cluster Randomised Controlled Trial of a Home-based Depression Care for Older People Delivered by Lay Providers in Nigeria (INDIGO)

U

University of Ibadan

Status

Not yet enrolling

Conditions

Depression in Old Age

Treatments

Behavioral: emhGAP-Age

Study type

Interventional

Funder types

Other

Identifiers

NCT06125899
220684/Z/20/Z

Details and patient eligibility

About

The aim of this hybrid (Effectiveness-Implementation) cluster randomised controlled clinical trial is to test the feasibility of implementing an age-appropriate electronic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-Age) in routine home-based care of older Nigerians with depression. The main questions it aims to answer are:

  1. Whether the emhGAP-Age demonstrate sufficient signals of effectiveness in the identification and home management of late life depression to permit for further exploration in a fully powered clinical trial?

  2. What are the logistical, programmatic, and operational requirements for a home-delivered emhGAP-Age in a sample of older people with depression in Nigeria? Consenting older participants with depression in the intervention arm will receive treatment based on emhGAP-Age which consists of;

    • Adapted electronic generic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-IG)
    • Adapted Problem-Solving Therapy (PST-PC)
    • Support/supervision of providers
    • Links to social support resources. Researchers will compare with treatment based on the basic specification in the generic emhGAP-IG (consisting of basic psychoeducation and stress reduction) for effects on depression remission.

Enrollment

110 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 60 years,
  2. PHQ-9 score of ≥11 during routine consultation

Exclusion criteria

  1. Severe co-morbidity requiring urgent attention.
  2. Severe cognitive impairment/dementia (Community Screening Instruments for Dementia score≤ 20) .
  3. Active suicidal intention.
  4. Evidence of bipolar/psychosis/severe substance use disorders.
  5. Planning to move out of the study catchment area within 6 months.
  6. Refusing/lacking capacity to consent/accent

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

110 participants in 2 patient groups

Age emhGAP-IG
Experimental group
Description:
* Adapted emhGAP-IG; * Adapted Problem-Solving Therapy (PST-PC) * Support/supervision of lay providers * Links to social support resources.
Treatment:
Behavioral: emhGAP-Age
Generic emhGAP-IG
Active Comparator group
Description:
Psychoeducation and stress reduction
Treatment:
Behavioral: emhGAP-Age

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems